Clotrimazole - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for clotrimazole and what is the scope of freedom to operate?
Clotrimazole
is the generic ingredient in twelve branded drugs marketed by Bayer Healthcare Llc, Fougera Pharms, Glenmark Pharms, Taro, Schering Plough, P And L, Schering, Novitium Pharma, Sciegen Pharms Inc, Tasman Pharma, Teva, Bayer Hlthcare, Teva Pharms, Bayer Pharms, Hikma, Padagis Us, and Thinq Pharm-cro Pvt, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for clotrimazole. Twenty-eight suppliers are listed for this compound.
Summary for clotrimazole
| US Patents: | 0 |
| Tradenames: | 12 |
| Applicants: | 17 |
| NDAs: | 31 |
| Drug Master File Entries: | 11 |
| Finished Product Suppliers / Packagers: | 28 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 37 |
| Patent Applications: | 7,083 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for clotrimazole |
| Drug Sales Revenues: | Drug sales revenues for clotrimazole |
| What excipients (inactive ingredients) are in clotrimazole? | clotrimazole excipients list |
| DailyMed Link: | clotrimazole at DailyMed |
Recent Clinical Trials for clotrimazole
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assiut University | N/A |
| Shanghai Pudong Decoding Life Institutes | N/A |
| Second Affiliated Hospital of Wenzhou Medical University | N/A |
Pharmacology for clotrimazole
| Drug Class | Azole Antifungal |
Medical Subject Heading (MeSH) Categories for clotrimazole
US Patents and Regulatory Information for clotrimazole
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | GYNIX | clotrimazole | TABLET;VAGINAL | 073249-001 | Feb 13, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | LOTRIMIN | clotrimazole | LOTION;TOPICAL | 018813-001 | Feb 17, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sciegen Pharms Inc | CLOTRIMAZOLE | clotrimazole | SOLUTION;TOPICAL | 216569-001 | Oct 16, 2023 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Bayer Healthcare Llc | GYNE-LOTRIMIN | clotrimazole | CREAM;VAGINAL | 018052-002 | Nov 30, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Tasman Pharma | CLOTRIMAZOLE | clotrimazole | SOLUTION;TOPICAL | 212281-001 | Jul 25, 2019 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Bayer Healthcare Llc | GYNE-LOTRIMIN 3 | clotrimazole | CREAM;VAGINAL | 020574-001 | Nov 24, 1998 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for clotrimazole
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Healthcare Llc | MYCELEX | clotrimazole | CREAM;TOPICAL | 018183-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Pharms | MYCELEX-G | clotrimazole | TABLET;VAGINAL | 019069-001 | Apr 19, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Healthcare Llc | MYCELEX | clotrimazole | CREAM;TOPICAL | 018183-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| Bayer Hlthcare | MYCELEX | clotrimazole | TROCHE/LOZENGE;ORAL | 018713-001 | Jun 17, 1983 | ⤷ Try a Trial | ⤷ Try a Trial |
| Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
